30816470 34393771 34465322 29364918 30841915 32128790 31119161 29284215 31678635 30551382 27448286 29097816 34420515 34445609 35562961 31555259 32111836 29731719 31164635 31760924 32933584 30760312 30268855 31781243 30895188 32871206 32825788 3269886 - Search Results

Year	Number of Results
2016	1
2017	3
2018	6
2019	11
2020	7
2021	8
2022	1

1

Role of bone marrow mesenchymal stem cells in the development of PQ‑induced pulmonary fibrosis.

Chen J, Si L, Zhou L, Deng Y. Chen J, et al. Mol Med Rep. 2019 Apr;19(4):3283-3290. doi: 10.3892/mmr.2019.9976. Epub 2019 Feb 20. Mol Med Rep. 2019. PMID: 30816470

2

Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices.

Vasse GF, Van Os L, De Jager M, Jonker MR, Borghuis T, Van Den Toorn LT, Jellema P, White ES, Van Rijn P, Harmsen MC, Heijink IH, Melgert BN, Burgess JK. Vasse GF, et al. Front Pharmacol. 2021 Jul 28;12:669037. doi: 10.3389/fphar.2021.669037. eCollection 2021. Front Pharmacol. 2021. PMID: 34393771 Free PMC article.

3

Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.

Li F, Wang D, Wang H, Chen L, Sun X, Wan Y. Li F, et al. Respir Res. 2021 Aug 31;22(1):239. doi: 10.1186/s12931-021-01832-7. Respir Res. 2021. PMID: 34465322 Free PMC article.

4

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.

Chamorro V, Morales-Cano D, Milara J, Barreira B, Moreno L, Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Cortijo J, Cogolludo Á, Barberá JA, Perez-Vizcaino F. Chamorro V, et al. PLoS One. 2018 Jan 24;13(1):e0191239. doi: 10.1371/journal.pone.0191239. eCollection 2018. PLoS One. 2018. PMID: 29364918 Free PMC article.

5

Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review.

Suen CM, Stewart DJ, Montroy J, Welsh C, Levac B, Wesch N, Zhai A, Fergusson D, McIntyre L, Lalu MM. Suen CM, et al. Stem Cell Res Ther. 2019 Mar 6;10(1):75. doi: 10.1186/s13287-019-1172-6. Stem Cell Res Ther. 2019. PMID: 30841915 Free PMC article.

6

Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.

Rajagopal K, Bryant AJ, Sahay S, Wareing N, Zhou Y, Pandit LM, Karmouty-Quintana H. Rajagopal K, et al. Br J Pharmacol. 2021 Jan;178(1):172-186. doi: 10.1111/bph.15036. Epub 2020 Apr 7. Br J Pharmacol. 2021. PMID: 32128790 Free PMC article. Review.

7

Function of Adipose-Derived Mesenchymal Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension through miR-191 via Regulation of BMPR2.

Zhang C, Wang P, Mohammed A, Zhou Z, Zhang S, Ni S, Tang Z. Zhang C, et al. Biomed Res Int. 2019 Apr 16;2019:2858750. doi: 10.1155/2019/2858750. eCollection 2019. Biomed Res Int. 2019. PMID: 31119161 Free PMC article.

8

Clinical assessment after human adipose stem cell transplantation into dogs.

Lee SH, Setyawan EMN, Choi YB, Ra JC, Kang SK, Lee BC, Kim GA. Lee SH, et al. J Vet Sci. 2018 May 31;19(3):452-461. doi: 10.4142/jvs.2018.19.3.452. J Vet Sci. 2018. PMID: 29284215 Free PMC article.

9

Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: A systematic review and meta-analysis.

Muhammad SA, Abbas AY, Saidu Y, Fakurazi S, Bilbis LS. Muhammad SA, et al. Biochimie. 2020 Jan;168:156-168. doi: 10.1016/j.biochi.2019.10.016. Epub 2019 Oct 31. Biochimie. 2020. PMID: 31678635

10

AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.

Hu Y, Feng Z, Feng W, Hu T, Guan H, Mao Y. Hu Y, et al. Biomed Pharmacother. 2019 Jan;109:1319-1326. doi: 10.1016/j.biopha.2018.10.109. Epub 2018 Nov 9. Biomed Pharmacother. 2019. PMID: 30551382 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results